Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium [PDF]
, 2014 The objective of this study was to assess the cost effectiveness of commonly used antidepressants as first-line treatment of major depressive disorder (MDD) in Belgium.
Annemans, Lieven +5 more
core +2 more sources
BMC Musculoskeletal Disorders, 2022 Background To investigate the analgesic effect of perioperative use of duloxetine in patients received total knee arthroplasty (TKA). Method This prospective randomized, double-blind, placebo-controlled trial study was registered in the Chinese Clinical ...
Mingcheng Yuan +4 more
doaj +1 more source
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
Diabetes, Metabolic Syndrome and Obesity, 2010 Lindsay Zilliox1, James W Russell1,21Department of Neurology, Neuromuscular Division, The University of Maryland School of Medicine, 2VA Maryland Health Care System, Baltimore, MD, USAIntroduction: Neuropathy is one of the most frequent ...
Russell J, Zilliox L
doaj +2 more sources
Duloxetine for the management of fibromyalgia syndrome
Journal of Pain Research, 2009 Beth A Scholz, Cara L Hammonds, Chad S BoomershineDepartment of Medicine, Vanderbilt University, Nashville, TN, USAAbstract: Fibromyalgia syndrome (FMS) is a widespread pain condition associated with a wide range of additional symptoms including fatigue,
Beth A Scholz +2 more
doaj
Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids. [PDF]
, 2019 Tramadol is one of the most commonly used analgesics worldwide, classified as having a low abuse potential by U.S. Drug Enforcement Agency, and often recommended in pain management guidelines.
Abagyan, Ruben +3 more
core +1 more source
Duloxetine in the Treatment of Major Depressive Disorder: An Open-Label Study [PDF]
, 2011 Background: Major depressive disorder (MDD) is a chronic and highly disabling condition. Existing pharmacotherapies produce full remission in only 30% to 40% of treated patients. Antidepressants exhibiting dual reuptake inhibition of both serotonin (5-HT)
Detke, Michael J. +5 more
core +1 more source
Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study [PDF]
, 2015 BACKGROUND: This study examined potential predictors of remission among patients treated for major depressive disorder (MDD) in a naturalistic clinical setting, mostly in the Middle East, East Asia, and Mexico.
Dueñas, Héctor +5 more
core +3 more sources
Comparing the effect of duloxetine with gabapentin in the treatment of diabetic peripheral neuropathy: A randomized clinical trial [PDF]
فصلنامه ابن سینا, 2014 Background: Diabetic neuropathy is the most common micro-vascular complications of diabetes. The drugs including gabapentin and duloxetine are often used for the treatment of pain associated with diabetic neuropathy.
B Forogh +9 more
doaj
Psychiatry and Clinical Psychopharmacology, 2018 Duloxetine is a serotonin-noradrenaline reuptake inhibitor. It has been increasingly used in child and adolescent psychiatric practice in recent years. In this paper, we presented a 16-year-old male patient diagnosed with generalized anxiety disorder who
Kemal Utku Yazici, Ipek Percinel Yazici
doaj +1 more source
Late-life depression : issues for the general practitioner [PDF]
, 2018 Late-life depression (LLD) is both a prevalent and life-threatening disorder, affecting up to 13.3% of the elderly population. LLD can be difficult to identify because patients mainly consult their general practitioner (GP) for somatic complaints ...
Declercq, Tom +4 more
core +1 more source